Neurogene (NGNE) Income towards Parent Company (2013 - 2026)

Neurogene (NGNE) has 14 years of Income towards Parent Company data on file, last reported at -$38.3 million in Q1 2026.

• Quarterly Income towards Parent Company fell 63.53% year-over-year to -$38.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$112.0 million (up 2.28% YoY) and the FY2025 annual result came in at -$231.6 million, down 22.45% from the prior year.
• Income towards Parent Company fell to -$38.3 million in Q1 2026, from -$25.1 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$11.9 million in Q2 2023 to a low of -$49.8 million in Q4 2022.
• A 5-year average of -$24.9 million and a median of -$23.4 million in 2025 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2022 — Income towards Parent Company soared 72.34% — and 2024, when it plunged 296.86%.
• Tracing NGNE's Income towards Parent Company over 5 years: stood at -$49.8 million in 2022, then soared by 71.97% to -$14.0 million in 2023, then slumped by 37.74% to -$19.2 million in 2024, then sank by 30.34% to -$25.1 million in 2025, then sank by 52.65% to -$38.3 million in 2026.
• The last three Income towards Parent Company figures came in at -$38.3 million (Q1 2026), -$25.1 million (Q4 2025), and -$24.0 million (Q3 2025), per Business Quant data.